Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1648 1671 1672
This examiner grants 58% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17046559 | MAMMALIAN MHC PEPTIDE DISPLAY AS AN EPITOPE SELECTION TOOL FOR VACCINE DESIGN | Non-Final OA | ETH Zürich |
| 18360631 | Methos for detection of microorganisms | Final Rejection | LABORATORY CORPORATION OF AMERICA HOLDINGS |
| 18068782 | Compositions, Kits, and Systems for the Rapid Detection of Bacteria Using Recombinant Bacteriophage to Express an Indicator Subunit | Non-Final OA | Laboratory Corporation of America Holdings |
| 17923118 | MOLECULAR TRANSPORT FOR VIRAL AGENTS | Non-Final OA | McMaster University |
| 17291879 | COMPOSITIONS AND METHODS | Final Rejection | Oxford University Innovation Limited |
| 17712600 | VACCINE AND THERAPEUTIC COMPOSITIONS COMPRISING ANTIGEN-CONJUGATED VIRAL CAPSIDS | Final Rejection | Board of Trustees of Michigan State University |
| 17709571 | VIRUS DETECTION VIA PROGRAMABLE TYPE III-A CRISPR-CAS SYSTEMS AND METHODS | Final Rejection | The Florida State University Research Foundation, Inc. |
| 17924784 | RSV VACCINE BEARING ONE OR MORE P GENE MUTATIONS | Non-Final OA | The United States of America,as represented by the Secretary,Department of Health and Human Services |
| 18583389 | METHOD FOR THE PROPHYLAXIS OR TREATMENT OF CORONAVIRUS INFECTION USING AN IMMUNOMODULATOR AND VACCINE COMPOSITIONS COMPRISING THE SAME | Non-Final OA | ADVAGENE BIOPHARMA CO., LTD. |
| 18058169 | VIRAL NUCLEIC ACID MOLECULES, AND COMPOSITIONS AND METHODS OF USE THEREOF | Non-Final OA | Centre for Virology, Vaccinology and Therapeutics Limited |
| 18245987 | HIGH THROUGHPUT METHODS AND PRODUCTS FOR SARS-COV-2 SERO-NEUTRALIZATION ASSAY | Non-Final OA | INSTITUT PASTEUR |
| 18270590 | SARS-COV-2 PROTEIN-DERIVED PEPTIDE AND VACCINE CONTAINING SAME | Non-Final OA | Cancer Precision Medicine, Inc. |
| 17802030 | METHOD FOR EVALUATING VIRAL CLEARANCE CAPABILITY | Final Rejection | ASAHI KASEI LIFE SCIENCE CORPORATION |
| 17801055 | DESIGNER PEPTIDES AND PROTEINS FOR THE DETECTION, PREVENTION AND TREATMENT OF CORONAVIRUS DISEASE, 2019 (COVID-19) | Non-Final OA | United Biomedical, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy